ICER - International Biopharmaceutical Industry

Current Edition

news

As Congress weighs drug price restraints, ICER calls out ‘unsupported’ increases

Congress is considering legislation that could force drugmakers to pay steep rebates to Medicare for patent-protected drugs that have price increases exceeding inflat...

19 November 2021 news Congress | drug price

Continue Reading →

news

PhRMA criticizes ICER in latest skirmish over valuing drugs

Industry lobbying group PhRMA on Thursday warned the use of cost-effectiveness estimates like those developed by the Institute for Clinical and Economic Review co...

1 June 2018 news Drugs | ICER

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

As Congress weighs drug price restraints, ICER calls out ‘unsupported’ increases

PhRMA criticizes ICER in latest skirmish over valuing drugs

International Biopharmaceutical Industry